PhaseBio Pharmaceuticals, Inc. (PHAS)
Net Income
$27.84M
TTM · Period ending: · USD
PHAS Net Income
Latest reported$27.84Mperiod ending
Latest reported$27.84Mperiod ending
PHAS Net Income (-$9.22M → $27.84M)
Annual net income
High-resolution chart · PNG
PHAS net income history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income (USD) |
|---|---|
| -131,071 | |
| -98,565,000 | |
| -39,247,000 | |
| -23,846,000 | |
| -10,247,000 | |
| -9,220,000 |